Characterization of real-world clinical and pathological differences between HER2-0 and HER2-low localized breast cancer
Cancer Treatment and Research Communications · 2026 · 47 · 101204
DOI: 10.1016/j.ctarc.2026.101204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Milla Hollmén und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and FICAN West Cancer Center, Turku University Hospital and University of Turku, Turku, Finland; Doctoral Program in Clinical …. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Turku University Foundation, Lounais-Suomen Syöpäyhdistys, Turun Yliopisto.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology and FICAN West Cancer Center, Turku University Hospital and University of Turku, Turku, Finland; Doctoral Program in Clinical Research, University of Turku, Turku, Finland. Electronic address: mil…
- Department of Biostatistics, University of Turku and Turku University Hospital, Turku, Finland.
- Department of Oncology and FICAN West Cancer Center, Turku University Hospital and University of Turku, Turku, Finland.
- Department of Oncology and FICAN West Cancer Center, Turku University Hospital and University of Turku, Turku, Finland; Cancer Research Unit, Institute of Biomedicine, University of Turku, Turku, Finland.
Förderung
- Turku University Foundation
- Lounais-Suomen Syöpäyhdistys
- Turun Yliopisto
- Finnish Medical Foundation
Zitieren
APA
Hollmén, M., Löyttyniemi, E., Juhanoja, E., Vihinen, P., & Sundvall, M. (2026). Characterization of real-world clinical and pathological differences between HER2-0 and HER2-low localized breast cancer. Cancer Treatment and Research Communications, 47, 101204. https://doi.org/10.1016/j.ctarc.2026.101204
Vancouver
Hollmén M, Löyttyniemi E, Juhanoja E, Vihinen P, Sundvall M. Characterization of real-world clinical and pathological differences between HER2-0 and HER2-low localized breast cancer. Cancer Treatment and Research Communications. 2026;47:101204. doi:10.1016/j.ctarc.2026.101204
BibTeX
@article{Hollmn2026,
author = {Hollmén, Milla and Löyttyniemi, Eliisa and Juhanoja, Eeva and Vihinen, Pia and Sundvall, Maria},
title = {Characterization of real-world clinical and pathological differences between HER2-0 and HER2-low localized breast cancer},
journal = {Cancer Treatment and Research Communications},
year = {2026},
volume = {47},
pages = {101204},
doi = {10.1016/j.ctarc.2026.101204}
}
EUVIMED